Overzicht Proefschriften
Tips in using the search/filter fieldsGo to page:
- of 5
- >
Displaying 1-50 of 215 results.
Titel | Promovendus | Promotor 1 | Promotor 2 | Copromotor 1 | Copromotor 2 | Universiteit | Promotiejaar | Trefwoorden |
---|---|---|---|---|---|---|---|---|
Integrated pharmaceutical care: cooperation between pharmacist, general practioner, and patient and the development of a pharmaceutical care plan | Geurts M.M.E., PhD | Gier J.J. de, prof. dr. | Brouwers J.R.B.J., prof. dr. | Graeff P.A. de, prof. dr. | Rijksuniversiteit Groningen (RUG) | 2015 | ||
Medication safety in Vietnamese hospital: a focus on medication errors and safety culture | Nguyen T.H., PhD | Taxis K., prof. dr. | Haaijer-Ruskamp F.M., prof. dr. | Brouwers J.R.B.J., prof. dr. | Rijksuniversiteit Groningen (RUG) | 2014 | ||
Driving-impairing medicines and traffic safety: patients' perspectives | Monteiro S.P., PhD | Gier J.J. de, prof. dr. | Dijk C.E.M.J. van, dr. ir. | Rijksuniversiteit Groningen (RUG) | 2014 | |||
Improving the physical health of people with severe mental illness : the need for tailor made care and uniform evaluation of interventions | Hasselt F.M. van, PhD | Loonen A.J.M., prof. dr. | Oud M.J.T., dr. | Krabbe P.F.M., dr. | Rijksuniversiteit Groningen (RUG) | 2013 | ||
The role of efflux and influx transporters in the disposition of digitalis-like compounds | Gozalpour E., PhD | Russel F.G.M., prof. dr. | Radboud Universiteit (RU) | 2015 | ||||
The many faces of Na+, K+-ATPase: understanding the role of human isoforms in health and disease | Weigand K.M., PhD | Russel F.G.M., prof. dr. | Radboud Universiteit (RU) | 2015 | ||||
Vascular adaptation to pregnancy and relaxin | Drongelen J. van, PhD | Smits P., prof. dr. | Lotgering F.K., prof. dr. | Radboud Universiteit (RU) | 2014 | |||
Optimizing cancer therapy. A focus on molecular imaging | Gaykema S.B.M., PhD | Vries E.G.E. de, prof. dr. | Lub-de Hooge M.N., dr. | Rijksuniversiteit Groningen (RUG) | 2014 | |||
Patient perspectives in the benefit-risk evaluation of drugs | Vries S.T. de, PhD | Denig P., prof. dr. | Haaijer-Ruskamp F.M., prof. dr. | Zeeuw D. de, prof. dr. | Rijksuniversiteit Groningen (RUG) | 2015 | ||
Pharmacokinetics and optimal exposure of antifungal drugs in critically ill patients | Elst K.C.M. van der, PhD | Kosterink J.G.W., prof. dr. | Werf T.S. van der, prof. dr. | Uges D.R.A., prof. dr. | Alffenaar J.W.C., dr. | Rijksuniversiteit Groningen (RUG) | 2015 | |
Preclinical targeting of the tumor microenvironment. Possibilities and consequences | Arjaans M., PhD | Vries E.G.E. de, prof. dr. | Schröder C.P., dr. | Timmer-Bosscha H., dr. | Rijksuniversiteit Groningen (RUG) | 2015 | ||
The role of endogenous H2S production during hybernation and forced hypothermia: towards safe cooling and rewarming in clinical practice | Dugbartey G.J., PhD | Henning R.H., prof. dr. | Bouma H.R., PhD | Rijksuniversiteit Groningen (RUG) | 2015 | |||
The influence of the sample matrix on LC-MS/MS method development and analytical performance | Koster R.A., PhD | Uges D.R.A., prof. dr. | Kosterink J.G.W., prof. dr. | Alffenaar J.W.C., dr. | Rijksuniversiteit Groningen (RUG) | 2015 | ||
Molecular imaging of tumor characteristics to support targeted therapies: a preclinical focus on HER2, HER3, c-MET, IGF-1R and VEGF imaging. | Terwisscha van Scheltinga A.G.T., PhD | Vries E.G.E. de, prof. dr. | Kosterink J.G.W., prof. dr. | Lub-de Hooge M.N., dr. | Schröder C.P., dr. | Rijksuniversiteit Groningen (RUG) | 2013 | |
Human in vivo studies on the non-glycaemic effects of thiazolidinedione derivatives | Rennings A.J.M., dr. | Smits P., prof. dr. | Tack C.J.J., prof. dr. | Radboud Universiteit (RU) | 2014 | |||
Clinical pharmacology of novel anticancer agents: bioanalysis - clinical pharmacokinetics - mass balance studies | Nijenhuis C.M., PhD | Beijnen J.H., prof. dr. | Schellens J.H.M., prof. dr. | Rosing H., dr. | Universiteit Utrecht (UU) | 2016 | ||
Variability in drug response: personalized diabetes care | Petrykiv S.I. | Lambers Heerspink H.J., prof. dr. | Zeeuw D. de, prof. dr. | Laverman G.D., dr. | Rijksuniversiteit Groningen (RUG) | 2017 | ||
Strategies for optimization of aminoglycoside and vancomycin therapies | Maarseveen E.M. van, PhD | Neef C., prof. dr. | Touw D.J., prof. dr. | Zanten A.R. van, dr. | 2014 | |||
Preclinical molecular imaging of target expression and target dynamics in cancer. | Pool M., PhD | Vries E.G.E. de, prof. dr. | Lub-de Hooge M.N., dr. | Terwisscha van Scheltinga A.G.T., PhD | Rijksuniversiteit Groningen (RUG) | 2017 | ||
Towards understanding interchangeability of generic drugs | Yu Y, dr | Neef C., prof. dr. | Burger D.M., prof. dr. | Universiteit Maastricht (UM) | 2017 | |||
Assessing the impact of gout:validating and understanding outcomes | Spaetgens B.P.A., dr | Boonen A.E.R.C.H., prof. dr. | Vries F. de, dr. | Universiteit Maastricht (UM) | 2017 | |||
Effects of perioperative medication on hemodynamics and blood loss | Haelst I.M.M. van, PhD | Egberts A.C.G., prof. dr. | Kalkman C.J., prof. dr. | Klei W.A. van, prof. dr. | Universiteit Utrecht (UU) | 2013 | ||
Training physicians in electronic prescribing | Stiphout F. van, PhD | Braak E.W.M.T. ter, prof. dr. | Egberts A.C.G., prof. dr. | Zwart-van Rijkom J.E.F., dr. | Aarts J.E.C.M., dr. | Universiteit Utrecht (UU) | 2016 | |
Medication management in homecare patients | Sino C.G.M., PhD | Schuurmans M.J., prof. dr. | Egberts A.C.G., prof. dr. | Universiteit Utrecht (UU) | 2013 | |||
Acute and chronic pain after cardiac surgery | Gulik L. van, PhD | Knibbe C.A.J., prof. dr. | Tibboel D., prof. dr. | Bruins P., dr. | Universiteit Leiden (UL) | 2014 | Acute pain; Intensive Care Unit; Chronic pain; Cardiac surgery; Pain management; | |
ADHD medication use and long-term consequences | Ban E.F. van den, PhD | Egberts A.C.G., prof. dr. | Swaab-Barneveld J.T., prof. dr. | Heerdink E.R., dr. | Universiteit Utrecht (UU) | 2014 | ADHD medication use; Long-term consequences; | |
Pediatric type 1 and 2 diabetes mellitus : epidemiology, comorbidities, and medication utilization | Fazeli Farsani S., PhD | Boer A. de, prof. dr. | Knibbe C.A.J., prof. dr. | Vorst M.M.J. van der, dr. | Mantel-Teeuwisse A.K., dr. | Universiteit Utrecht (UU) | 2015 | Adolescents; Children; Comorbidities; Epidemiology; Medication use; Diabetes mellitus; UIPS; |
Adverse drug reactions of angiotensin-converting enzyme inhibitors : towards precicion medicine | Mahmoud Pour S.H., PhD | Boer A. de, prof. dr. | Asselbergs F.W., prof. dr. MD FES | Maitland-van der Zee A.H., prof. dr. | Universiteit Utrecht (UU) | 2016 | Adverse drug reaction; Pharmacoepidemiology; Pharmacovigilance; ACE Inhibitors | |
Adverse drug reactions in individual patient care : documentation and prevention of represcription | Linden C.M.J. van der, PhD | Korsten H.H.M., prof. dr. | Egberts A.C.G., prof. dr. | Jansen P.A.F., dr. | Grouls R.J.E., dr. | Technische Universiteit Eindhoven (TUE) | 2013 | Adverse drug reactions; Patient care; Prevention; Represcription; |
Assessing long-term and rare adverse effects of medicines | Duijnhoven R.G., PhD | Boer A. de, prof. dr. | Hoes A.W., prof. dr. | Bruin M.L. de, prof. dr. | Straus S.M.J.M., dr. | Universiteit Utrecht (UU) | 2016 | Adverse effects; Case-control studies; Clinical trials; Cohort studies; Long-term consequences; Medicines; Regulatory; |
Albuminuria: more than a renal risk marker? | Belt S.M. van den, PhD | Zeeuw D. de, prof. dr. | Lambers Heerspink H.J., prof. dr. | Rijksuniversiteit Groningen (RUG) | 2018 | Albuminuria; Risk markers; | ||
Adequate antimicrobial treatment in elderly patients | Haeseker M.B., dr | Verbon A., prof.dr. | Stolk L.M.L., dr | Universiteit Maastricht (UM) | 2015 | Antibiotics; Elderly; | ||
Precision anticoagulation with vitamin K antagonists in children | Maagdenberg H., PhD | Boer A. de, prof. dr. | Maitland-van der Zee A.H., prof. dr. | Bierings M.B., dr. | Universiteit Utrecht (UU) | 2018 | Anticoagulation; Thrombosis; Bleedings; Children; Adolescents; Pharmacogenetics; Acenocoumarol; Phenprocoumon; Personalized medicine; Medicines; | |
Building a clinical pharmacology framework for the safe and effective use of antifungal agents | Lempers VJC | Burger D.M., prof. dr. | Brüggemann R.J.M., PhD | Aarnoutse R.E., dr. | Radboud Universiteit (RU) | 2016 | Antifungal drugs; Clinical pharmacology; | |
Pharmacokinetics of antifungal drugs in severely ill patients | Wanrooy M.J.P. van, PhD | Werf T.S. van der, prof. dr. | Kosterink J.G.W., prof. dr. | Uges D.R.A., prof. dr. | Alffenaar J.W.C., dr. | Rijksuniversiteit Groningen (RUG) | 2015 | Antifungal drugs; Pharmacokinetics; |
The road to tailor made azole antifungal therapy | Brüggemann R.J.M., PhD | Burger D.M., prof. dr. | Verweij P.E., prof. dr. | Blijlevens N.M.A., dr. | Radboud Universiteit (RU) | 2011 | Antifungal; clinical pharmacology | |
Red wine polyphenols and vascular function | Botden I.P.G., PhD | Danser A.H.J., prof. dr. | Sijbrands E.J.G., prof. dr. | Langendonk J.G., dr. | Erasmus Universiteit Rotterdam (EUR) | 2012 | Antihypertensive drugs; Cardiovascular disease; Pharmacology; | |
Natriuretic peptides, diagnostics and prognostic biomarkers | Rutte J.H.W., dr. | Danser A.H.J., prof. dr. | Meiracker A.H. van den, dr. | Erasmus Universiteit Rotterdam (EUR) | 2010 | Antihypertensive drugs; Pharmacology; Kidney; Natriuretic peptides; Renine-angiotensine system; | ||
Antiplatelet drugs for secondary prevention of cardiovascular diseases : drug utilization, effectiveness, and safety | Noorsyahdy A.Y., MD PhD | Boer A. de, prof. dr. | Klungel O.H., prof. dr. | Deneer V.H.M., dr. | Universiteit Utrecht (UU) | 2017 | Antiplatelet drugs; Secondary prevention; Myocardial infarction; Ischemic stroke; Cardiac arrest; Pharmacogenetics; | |
Antipsychotics, delirium and glucose in older patients | Keulen K. van, PhD | Egberts A.C.G., prof. dr. | Knol W., PhD | Heerdink E.R., dr. | Universiteit Utrecht (UU) | 2018 | Antipsychotics; Older patients; Delirium; Hypoglycemia; Hyperglycemia; Incapacitated patients; Glucose variability; | |
Optimizing protease inhibitor-based antiretroviral therapy for HIV-1 infected Thai adults and children | Lugt J. van der, dr. | Lange J.M.A., prof. dr. | Ananworanich J., dr. | Burger D.M., prof. dr. | Universiteit van Amsterdam (UvA) | 2010 | Antiretroviral; HIV; Pharmacokinetics; Clinical pharmacology; therapeutic drug monitoring | |
Towards better treatment outcomes in childhood asthma | Koster E.S., PhD | Raaijmakers J.A.M., prof. dr. | Maitland-van der Zee A.H., prof. dr. | Universiteit Utrecht (UU) | 2011 | Asthma; Children; Treatment Outcomes; Epidemiology; | ||
Individualized dosing of serotherapy in allogeneic hematopoietic cell transplantation | Admiraal R., PhD | Knibbe C.A.J., prof. dr. | Boelens J.J., dr. | Bredius R.G.M., dr. | Universiteit Leiden (UL) | 2017 | ATG; Population PK; Stem cell transplantation; Immune reconstitution; Serotherapy; | |
Implications of the cardiomyocyte stress response on protein homeostasis in atrial fibrillation | Wiersma M., PhD | Henning R.H., prof. dr. | Brundel B.J.J.M., dr. | Rijksuniversiteit Groningen (RUG) | 2016 | Atrial fibrillation; | ||
Targeting proteostasis in atrial fibrillation | Zhang D., PhD | Henning R.H., prof. dr. | Brundel B.J.J.M., dr. | Rijksuniversiteit Groningen (RUG) | 2015 | Atrial fibrillation; Modelling-&-simulations; | ||
Loss of proteostasis as a substrate for Atrial Fibrilation. | Meijering R.A.M., PhD | Henning R.H., prof. dr. | Brundel B.J.J.M., dr. | Rijksuniversiteit Groningen (RUG) | 2014 | Atrial fibrillation; Proteostasis; | ||
From data to models : reducing uncertainty in benefit risk assessment : application to chronic iron overload in children | Bellanti F., PhD | Danhof M., prof. dr. | Della Pasqua O.E., dr. | Universiteit Leiden (UL) | 2015 | Benefit-risk assessment; Pediatrics; Iron chelations; PK-PD modelling; Modelling-&-simulations; Multi-criteria-decision-analysis; Iron-overload; Deferiprone; Deferoxamine; | ||
Benefits and risks for the individual : anticoagulation for patients with atrial fibrillation | Ham H.A. van den, PhD | Leufkens H.G.M., prof. dr. | Klungel O.H., prof. dr. | Staa T.J. van, prof. dr. | Universiteit Utrecht (UU) | 2016 | Benefit-risk balance; Atrial fibrillation; Oral anticoagulants; Observational studies; Individuals; | |
Pharmacovigilance of biologicals : dynamics in post-approval safety learning | Vermeer N.S., PhD | Leufkens H.G.M., prof. dr. | Egberts A.C.G., prof. dr. | Bruin M.L. de, prof. dr. | Straus S.M.J.M., dr. | Universiteit Utrecht (UU) | 2015 | Biologicals; Biosimilars; Pharmacovigilance; Adverse drug reactions; Regulatory science; Traceability; Risk management plan; |
Monitoring patients using clozapine | Man W.H., PhD | Egberts A.C.G., prof. dr. | Solinge W.W. van, prof. dr. | Wilting I., dr. | Heerdink E.R., dr. | Universiteit Utrecht (UU) | 2018 | Biomarkers; Adherence; Monitoring; Sialorrhea; Inflammation; Glycopyrrolate; Schizophrenia; Antipsychotics; Pharmacovigilance; |
Go to page:
- of 5
- >